glp-1 receptor agonists list Benefits and Risks of Outlined Frontiers | GLP−1 receptor agonists
Description
Glucose-Dependent Insulinotropic Polypeptide Inhibits Cardiac Hypertrophy and Fibrosis in Diabetic Mice via Suppression of TGF-2
This effect is not observed in other GLP-1RAs and is currently being studied by the drug manufacturers in the FOCUS trial (NCT03811561)
Most patients will require more than one agent to control diabetes
A Bayesian neural network method for adverse drug reaction signal generation
Data Availability Statement Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
This helps establish a baseline before you begin treatment
